The role of ultrasound in the evaluation of the endometrium has been overshadowed by a large volume of literature about the ovaries and myometrium. In fact, aside from some investigations centering on the thickness of the endometrium in the normal woman and its relationship to the possibility of endometrial cancer, there has been little interest in the endometrium until very recently. Transvaginal sonography (TVS) has provided a modest improvement over transabdominal sonography (TAS) to image the endometrium and evaluate pathology; however, the gynecologic community relies heavily on endometrial biopsy (EMB), dilatation and curettage (D&C), and hysteroscopy for endometrial diagnosis.
The introduction of saline-infused hysterosonography (HSG) has revolutionized gynecologic ultrasound of the endometrium. The variety and frequency of endometrial disorders seen with HSG rivals and even surpasses that seen with hysteroscopy, a moderately invasive procedure. This article will attempt to define the role of ultrasound in the complex anatomy, physiology, and pathology of the endometrium.
Techniques

Transabdominal sonography
Many sonologists insist on performing TAS as a screening procedure prior to performing any other ultrasound techniques such as TVS or HSG. TAS requires a full bladder and is often uncomfortable and time-consuming, particularly in the postmenopausal woman. For specific evaluation of the endometrium in the patient with a normal-sized uterus, TAS is unnecessary as the first step [1] [2] [3] . Furthermore, as the patient becomes well hydrated to fill her bladder for TAS, a partially full bladder interferes with TVS and HSG, which are best performed with the bladder completely empty [4] .
When the uterus and ovaries are incompletely visualized on TAS, it may the be appropriate to perform TAS, but if the uterus is enlarged and anteverted, a full bladder may not be necessary for visualization of the myometrium and ovaries. The uterus can act as an acoustic window.
Transvaginal sonography
Since its introduction in the mid-1980s, TVS has become the standard way to image the female pelvis in the gynecologic community and an important adjunct to the radiologist/sonologist. End-fire endoluminal probes of 5-9 MHz have been used. The patient, technologist/ sonographer, or sonologist can insert the probe. Imaging is in the coronal or sagittal plane, and the endometrium is well suited for this technique due to its proximity to the vaginal apex, allowing for high resolution scanning [1] [2] [3] [4] [5] (Fig. 1) .
There is continuing interest in the role of spectral and color Doppler imaging for the endometrium. Either of these techniques may have a role in the differential diagnosis of endometrial abnormalities and are available as adjunctive techniques on most modern ultrasound machines. As with other Doppler applications in the pelvis, there is considerable overlap of benign and malignant abnormalities when measuring indices of resistance, which, when decreased, suggest angioneogenesis associated with neoplasms. Unfortunately, the normal cyclic physiology of the female pelvis produces angioneogenesis in both ovaries and uterus, making these analyses difficult [2] . However, as will be discussed, color Doppler may have a role in differentiating endometrial polypoid lesions.
Hysterosonography
Although introduced as early as 1986 for potential evaluation of tubal patency, HSG has only recently become popular as an important technique for endometrial evaluation [6] [7] [8] . In our department, the procedure is per- formed following TVS or TAS and TVS, without significant preparation. We use a lighted speculum and a 5-Fr balloon-bearing commercially available HSG catheter (Ackrad Labs, Cranford, NJ).
The patient is placed in the lithotomy position, and the speculum is inserted. The cervix is identified and swabbed with iodine solution. A long cotton swab, available in gynecology departments, is useful. The external cervical os is identified, and the outer stiffener of the catheter system is placed as far into the os as possible. The catheter is then advanced, and the balloon inflated with about 0.5-1 cc of saline, being careful not to instill air, which can create an acoustic artifact. If there is resistance to advancing the catheter, gentle pressure may be applied, and the catheter will often advance over what may be adhesions or areas of stenosis. Rarely, it may be necessary to leave the catheter tip in the cervical canal and inflate the balloon to prevent dislodgment. TAS can be useful to monitor insertion in difficult cases. In very difficult catheterizations, a tenaculum may help stabilize the cervix, or a cervical dilator may open the canal for catheterization. Alternative catheters include urethral balloon catheters, insemination catheters, and pediatric feeding tubes [6] [7] [8] . The speculum is then carefully removed without dislodging the catheter. A speculum that disengages or has one open side can facilitate this maneuver.
Following successful placement of the catheter into the endometrial cavity, sterile saline is instilled with transvaginal real-time ultrasound monitoring. Depend-ing on the patient's age, uterine morphology, and presence of pathology, we instill 3-40 cc of saline. To prevent leakage of fluid, it is helpful to put traction on the catheter to seal the internal os with the balloon. The catheter should be flushed with saline prior to insertion so no air is instilled. Fluid instillation should be slow to decrease the level of cramping. Some have suggested preparation with ibuprofen to decrease cramping. Images are obtained just after balloon deflation and upon removal of the catheter to image the lower uterine segment free of the catheter artifact. Antibiotics are not routinely given after the procedure [6] (Figs. 2, 3) .
In the premenopausal patient, HSG should be performed in the proliferative phase of the menstrual cycle, if possible, to help separate endometrial hyperplasia from secretory endometrium. In the postmenopausal patient, timing of the exam is not as important unless the patient is on cyclic hormonal replacement [7] .
Normal anatomy and physiology
The premenopausal patient
The endometrium can be seen on TAS, TVS, and HSG. Measurements of the endometrial thickness are best made on TVS or HSG because of the proximity of the transducer to the uterus. The measurement is best made in the sagittal plane, and the convention is to use the full thickness of the endometrium minus any fluid that may be present [2, 3, 8] (Figs. 1, 3A , 4A, 5).
In the normal menstrual cycle, day 1 represents the first day of menstrual flow. A scan performed on that day may show fluid or blood clot in the endometrial cavity (Fig. 5 ). The endometrium is thinnest on the last day of flow, typically on days 3-5. Endometrial thickness in the proliferative phase of the cycle (days 5-14) is 2-8 mm. In the proliferative phase, the endometrium is hypoechoic, with the lumen maintaining a thin hyperechoic appearance [9, 10] (Fig. 1) . Occasionally, the junctional zone between the endometrium and the inner myometrium may appear hypoechoic to the inner zone myometrium and may give the appearance of a halo [11] ( Fig. 1 ). Beginning at day 14, when many women ovulate, the secretory phase begins (Fig. 6 ). The endometrium becomes thicker, reaching a maximal thickness of 12 mm [9, 10] . Furthermore, the endometrium becomes more echogenic due to the change in glandular content from absence of secretions to glycogen and mucin [2, 10] (Figs. 2, 6 ). The boundary between the endometrium and the inner myometrium again may be hypoechoic and is termed the ''junctional zone.'' The exact histologic correlate of this zone remains controversial, but it is probably a compact inner layer of myometrium [11] (Figs. 1, 4A, 6A).
In the premenopausal patient, HSG can provide additional detail of the endometrial thickness and morphology. The addition of color or power Doppler can allow analysis of blood flow and resistance (Fig. 2) .
The postmenopausal patient
Because most pathologic conditions of the endometrium occur during perimenopause and postmenopause, there is much interest in the sonographic appearance in this group of patients. The major clinical problem in this patient group is abnormal bleeding. The amount and significance of the bleeding depends on the presence and type of exogenous hormone replacement therapy (HRT). Table 1 outlines the major forms of HRT and the expected endometrial thicknesses for patients with and without HRT. In the patient without HRT, an endometrial thickness greater than 5-6 mm may be abnormal, particularly at 5 years postmenopause and beyond, and the asymptomatic patient may require, at minimum, a follow-up examination. In patients with HRT, endometrial thickness may approach that seen during premenopause, particularly for those women on cyclic therapy and those less than 5 years from the onset of menopause. As with the premenopausal population, HSG may be extremely useful for confirmation of normality or for defining pathology [4-8, 12, 13] (Figs. 3,  7, 8 ).
Clinical problem solving with ultrasound
Screening for endometrial cancer
There is considerable debate in the literature about the value of screening for endometrial cancer in the asymptomatic patient. Osmers et al. [14] argued that a detection rate of 3.5% when screening asymptomatic women makes screening a worthwhile investment. Unfortunately, like screening for prostate cancer, screening for endometrial cancer has not been subjected to rigorous cost-benefit analysis, taking into account the lead time bias that is present in any screening situation. Is there any data to indicate that an earlier diagnosis of endometrial cancer affects the cure rate and survival? Would not most of these patients eventually present with abnormal uterine bleeding, particularly those in postmenopause [15] ?
If screening for endometrial cancer were to be found economically feasible, the data suggest that an endometrial thickness of 4 mm or less in the asymptomatic postmenopausal patient would exclude all cases of endometrial cancer [14] . In premenopausal patients, there is no role for screening for endometrial cancer. 
Abnormal uterine bleeding in premenopause
It is difficult to define the exact cause of abnormal or irregular uterine bleeding (AUB) in the premenopausal patient, but pathologic conditions of the endometrium or myometrium often are factors. Anovulatory cycles are a common cause, but hyperplasia, polyps, submucous myomas, and carcinoma are possible and of concern to the patient. Clinical procedures often used to evaluate patients with AUB include D&C and endometrial biopsy (EMB), with hysteroscopy reserved for complex cases with persistent bleeding [16] [17] [18] . Pa- tients with menorrhagia fall into a similar diagnostic dilemma as those with AUB because submucous leiomyomas and polyps are causes, as are generalized leiomyomas with uterine enlargement and adenomyosis. The value of ultrasound in evaluating and triaging these patients cannot be overemphasized. TAS may be indicated in the patient with an enlarged uterus at the time of physical examination, but TVS and HSG are critical in the overall evaluation and clinical care of patients with abnormal bleeding. Although an endometrial diameter of 4 mm or less excludes most pathology, our experience suggests that HSG is useful even in patients with thin endometria (Fig. 8) . When HSG is performed in premenopausal patients, it is best done in the proliferative phase of the cycle. The sonologist should carefully evaluate the endometrial texture to search for small filling defects that can be better evaluated with HSG [16, 19, 20] (Fig. 9) .
Although leiomyomata can often be detected and followed into the endometrium with TVS, HSG provides a clearer evaluation of the size of the mass and can help assess whether the patient is a candidate for an hysteroscopic myomectomy. If the leiomyoma is intracavitary or predominantly submucous, hysteroscopic resection is feasible (Fig. 10) . If the lesion is predominantly mural, hysterectomy is the only choice if the AUB can be attributed to the leiomyoma [16, 17, 21] . Cicinelli et al. [22] suggested a transabdominal approach to HSG imaging when evaluating leiomyomata.
Another cause of AUB is endometrial hyperplasia. It is most commonly cystic, but the cysts are microscopic. Adenomatous hyperplasia, the other form, is sonographically identical in appearance. With TAS, TVS, and HSG, there is uniform increased endometrial echogenicity that can also be hypervascular with color Doppler [1, 2, 7, 17, 23] .
Merce et al. [24] described the role of spectral Doppler in the evaluation of the endometrium in patients with AUB. As with other Doppler evaluations attempting to separate benign from malignant histologies, the positive predictive value is poor and the information does not influence the eventual diagnostic or therapeutic outcome. Others have used uterine artery waveforms to assess endometrial pathology and have found some success in the evaluation of the resistive index in separating cancer from benign disorders [25] . We have not used this technique and feel as Granberg and Bourne [4, 15] that it does not add significantly to the specificity obtained with HSG or change clinical management of the patient.
Postmenopausal bleeding
Any postmenopausal patient who is not scheduled to bleed from HRT suffers from postmenopausal bleeding (PMB) and should have a diagnostic evaluation. The obvious fear in this patient population is endometrial cancer. In the past, diagnostic tests such as EMB, D&C, hysteroscopy, and even hysterectomy were used to allay the fear of cancer. Even though endometrial atrophy is the most common cause of PMB and cancer is only seen in about 10% of patients with PMB, defining the absence of significant pathology is important in this patient population [26] . Finding less significant but treatable abnormalities, such as an endometrial polyp, is important for the psychological health of the patient. In addition, endometrial polyps may be associated with or progress to endometrial cancer, and polypectomy accompanied by D&C may be indicated in these patients [27] .
Ultrasound has a definite role in the evaluation of patients with PMB. Conventional diagnostic procedures have significant false-negative rates for the common conditions such as polyp, leiomyoma, and cancer [15] . Even though hysteroscopy performed in the office can be cost-effective in defining the etiology of PMB, polypectomy and directed biopsy is difficult with this instrument and most gynecologists are reluctant to perform this uncomfortable procedure in an office setting.
We have begun to study every patient with PMB with TVS followed by HSG. Our experience has been that using TVS alone cannot define all of the abnormalities and that normal thickness endometria can harbor polyps or submucous leiomyomata (Figs. 8, 9, 11) . Furthermore, defining a thickened endometrium does little to determine the etiology, and many polyps appear as a thickened endometrium at first glance (Fig. 12) . However, in the multicenter ''Nordic Trial,'' 35% of women with PMB with endometrial thicknesses of 6-10 mm had atrophic endometria histologically [28] (Figs. 3, 7) .
Several features favor an endometrial polyp with TVS and confirm the presence of a polyp with HSG. Cystic spaces in the endometrium are characteristic of polyps [29] [30] [31] [32] . The spaces may represent dilated glands seen histologically (Fig. 13) . Polyps tend to be on a thin stalk and with color Doppler have a single vessel entering the stalk [6] (Figs. 8, 9, 12) . The vascularity of a polyp is less than that of a pedunculated submucous leiomyoma, which can be mistaken for a polyp with HSG (Fig. 14) . Polyps may be multiple, and careful search for others is necessary when a large polyp is initially discovered (Fig. 12) . Polyps are typically echogenic with TVS and with HSG, although they are occasionally hypoechoic with TVS. The increased echogenicity with HSG is related to the differential echodensity with the surrounding fluid and to acoustic enhancement (Fig. 9) .
Submucous leiomyomata are a cause of PMB. Leiomyomata are often inhomogeneous with mixed echogenicity, and they disrupt the endometrium [6, 7] . When a leiomyoma is large and has continuity with the myometrium, the distinction from a polyp or carcinoma is easy (Figs. 10, 14) . Occasionally, a submucous leiomyoma is pedunculated and mimics the appearance of a polyp. In this instance, differentiation is more difficult (Figs. 11, 15 ). Features suggesting leiomyoma include a broader base, irregular shape, and increased vascularity with color Doppler (Figs. 11, 14, 15 ). Our experience suggests that the pedunculated polyplike leiomyomata are more commonly the cause of PMB than the larger lesions connected to the myometrium.
As in the premenopausal woman, detection and staging of submucous leiomyomata can be useful in the preoperative decision of hysteroscopic versus open treatment of the lesion depending on the size and percentage of protrusion into the endometrial cavity. HSG is an ideal procedure to provide that information [21, 22] .
Although not a cause of bleeding, uterine adhesions or synechiae have been discovered in patients with PMB. Adhesions are probably the result of previous uterine instrumentation and are associated with infertility in premenopausal women [6, 7] (Fig. 16) . In addition, linear bands may be remnants of hemorrhage and only represent fibrin strands when they are seen shortly Fig. 11 . Polypoid submucous leiomyoma. A patient with postmenopausal bleeding. An initial TVS showed a thin endometrium. HSG demonstrates small irregular polypoid mass subsequently proven to be submucous leiomyoma. These can be extremely difficult to separate from denomatous polyps. A Sagittal image from TVS shows poorly defined thickened endometrium with inhomogeneity. B Transverse image from TVS shows very thick endometrium, with inhomogeneity consistent with endometrial cancer. C Transverse image during HSG demonstrates poor filling of the endometrial cavity due to large endometrial mass. The carcinoma extends deep into the myometrium (arrows). after EMB, a common scenario for this patient population. To decrease the incidence of false-positive synechiae, we usually wait at least 1 week after EMB prior to performance of HSG.
Exclusion of endometrial cancer is the goal of evaluating the patient with PMB. As a result, evaluation with ultrasound, Doppler, or HSG is only ancillary to a definitive biopsy either in the office or in the operating room [33] [34] [35] [36] . However, TVS demonstration of an endometrial thickness of 4 mm or less virtually excludes carcinoma with the same reliability as an EMB plus D&C. When TVS demonstrates a thin endometrium and the question asked is strictly related to presence or absence of cancer, biopsy is not necessary; in the Nordic Trial, the number of biopsies was decreased by 46% without loss of accuracy [28] . If an EMB is inadequate, as happens frequently, TVS with or without HSG can be used to determine if the inadequate tissue sample is due to endometrial atrophy or to a technical failure requiring further evaluation with D&C and hysteroscopy. In cases where the bleeding is sufficiently distressing to the patient, HSG should be done, with definitive therapy planned accordingly.
The appearance of endometrial cancer with TVS and HSG is well described. With TVS, the endometrium is diffusely thickened, irregular, and echogenic [1, 2] (Fig.  17) . Uncommonly, endometrial cancer is a broad-based polypoid mass [1] (Fig. 18) . Ultrasound has been advocated for assessing myometrial invasion by endometrial cancer [31, 32, [37] [38] [39] . Superficial invasion is associated with the preservation of the subendometrial halo, whereas deep invasion is associated with loss of the halo [38] .
Endometrial fluid
The incidental finding of fluid in the endometrial cavity is less ominous during premenopause than during postmenopause. In the presence of bleeding, fluid can often be seen. In the absence of bleeding during postmenopause, a fluid collection is often the result of cervical stenosis and can be due to any of the previously described etiologies of bleeding, although some series have suggested a very low incidence of cancer [4, 32, 40] . Unfortunately, it is often impossible to perform an EMB or even to perform D&C and hysteroscopy without a major surgical procedure to dilate the cervix.
One of the complications of long-standing fluid in the endometrial cavity is infection leading to pyometra (Fig. 19) , which often leads to hysterectomy. Ultrasound can be useful to discover the etiology of the fluid and to guide surgical or radiologic aspiration of the fluid.
Tamoxifen-related abnormalities
Tamoxifen is a commonly used drug for adjuvant treatment of breast cancer in postmenopausal women and is also being investigated for prophylaxis against breast cancer. The hormone has estrogenic and antiestrogenic effects and is the cause of endometrial and subendometrial abnormalities. Bleeding is common, but abnormalities are seen in the absence of bleeding. Screening for tamoxifen changes in the uterus may be indicated [41] .
Tamoxifen can lead to endometrial hyperplasia, carcinoma, and cystic subendometrial changes, which may be due to adenomyosis [42] [43] [44] . Tamoxifen is associated with an increased incidence of endometrial polyps; as a consequence, when cystic changes are identified in a thickened endometrium in patients on tamoxifen, HSG is necessary to define the pathology and guide further diagnosis and therapy [45] [46] [47] . When a polyp is identified, hysteroscopic removal is indicated (Fig. 13) . When hyperplasia or carcinoma is suggested, EMB or D&C should be done. If the changes are all subendometrial, no biopsy is necessary (Fig. 20) .
Conclusions
Modern gynecologic ultrasound has revolutionized the evaluation of women with common endometrial-related problems previously relegated to blind and inaccurate diagnostic procedures. The development and increasing popularity of HSG has led to increased understanding of the endometrium seen with TVS. It is now possible for the experienced sonologist to examine the endometrium with TVS and predict normality or abnormality and identify polyps, leiomyomata, or carcinoma. This possibility does not preclude performance of HSG, a safe, effective, and simple procedure, but it does provide for greater confidence in the results of TVS when HSG is contraindicated or not possible because of cervical stenosis.
With high-resolution TVS and HSG, we have developed an understanding of the normal endometrium and the normal variations with the various forms of HRT. In the presence of abnormal uterine bleeding, TVS and HSG will provide important information for accurate diagnosis and therapy in a large population of patients.
